| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |